nexviazyme – Lab DB

Pharmaceutical R&D

Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion

Teuku Ryan Jul 1, 2026 0

Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…

Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion

YOU MAY HAVE MISSED

Inside the Aging Bone Marrow: How Microenvironmental Inflammation Fuels Pre-Leukemic Clones and Blood Cancers

How Sheba Medical Center became OpenAI’s first international hospital partner

Scientists recreated what mice saw from brain activity alone

Einstein’s “spooky action” just survived one of physics’ most extreme tests